Impact BiomedicalIBO
13F holders, Q2 2025 (June 30)19holders +3
5new positions
2sold out
$0.65avg. 13F price*
At the end of Q2 2025, 19 institutions reported holding Impact Biomedical Inc. (IBO) in their 13F filings, up 3 from Q1 2025. 5 opened new positions and 2 sold out. The largest holders were BlackRock, Inc. ($164K), Geode Capital Management, LLC ($32K) and UBS Group AG ($26K).
- Company
- Impact Biomedical Inc.
- CUSIP
- 45259L205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $47K |
| Exits | 2 | $59K |
All 13F filers, Q1 2025 → Q2 2025: 345,483 shares bought and 223,273 shares sold, net +122,210 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| BlackRock, Inc. | 0.00% | Add +723.9% | 252,730 | $164K |
| Geode Capital Management, LLC | 0.00% | Add +115.0% | 49,869 | $32K |
| UBS Group AG | 0.00% | Add +145.7% | 39,725 | $26K |
| Vanguard Group Inc. | 0.00% | Reduce -74.3% | 32,437 | $21K |
| Susquehanna International Group, LLP | 0.00% | New | 30,824 | $20K |
| Two Sigma Investments, LP | 0.00% | New | 22,700 | $15K |
| State Street Corp. | 0.00% | No change | 11,797 | $8K |
| StoneX Group Inc. | 0.00% | New | 10,794 | $7K |
| HRT Financial LP | 0.00% | Reduce -84.8% | 10,326 | $6K |
| Citigroup Inc. | 0.00% | New | 8,784 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -61.5% | 1,449 | $938 |
| NFSG Corp | 0.00% | No change | 86 | $56 |
| Bank of America Corp. | 0.00% | Add +370.6% | 80 | $52 |
| FMR LLC | 0.00% | New | 36 | $23 |
| Wells Fargo & Company | 0.00% | Reduce -97.2% | 29 | $19 |
| Signature Resources Capital Management, LLC | 0.00% | No change | 4 | $3 |
| Danske Bank A/S | 0.00% | No change | 3 | $2 |
| Group One Trading LLC | 0.00% | No change | 1 | $1 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is IBO's weight in each manager's 13F, not the share of Impact Biomedical Inc. the manager owns.